Error: Could not add to watchlist. X

Allianz Global Investors Global Biotech Fund

+ Watchlist
DREGBIO:TT
42.20
TWD
0.16
0.38%
As of 04:30:00 ET on 07/02/2015.
Volume
0
Previous Close
42.04
52Wk Range
28.39 - 43.20
1 Yr Return
41.18%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
42.2
Total Assets (b TWD) (on 05/29/2015)
5.466
Inception Date
06/28/2002
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
FU TZU-PING "MARK"
Front Load Fee
2.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.80%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Alexion Pharmaceuticals Inc 52.13 k 304.99 m 7.86
Vertex Pharmaceuticals Inc 77.27 k 290.25 m 7.48
Celgene Corp 76.69 k 271.24 m 6.99
Biogen Inc 23.07 k 247.57 m 6.38
Medivation Inc 60.25 k 189.75 m 4.89
Gilead Sciences Inc 63.14 k 188.20 m 4.85
AMGN 5 ⅜ 05/15/43 4.52 k 166.85 m 4.30
Incyte Corp 66.14 k 152.89 m 3.94
Actelion Ltd 38.37 k 141.63 m 3.65
Sanofi 42.09 k 121.84 m 3.14
Profile
Allianz Global Investors Global Biotech Fund is an open-end unit trust establish ed in Taiwan. The Fund's objective is to seek long-term capital gain and secure stable income. The Fund invests primarily in equity securities issued by companies in the biotechnology sector. It also invests in local equities and government bonds (including convertibles) and financial debentures.
ADDRESS
Allianz Global Investors Taiwan Ltd
6F 378 Fu Shin North Road
Taipei
Taiwan
PHONE
886-2-2502-8889